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ABSTRACT
Background: mHealth applications assist workflow, helpmove towards equitable access to care,
and facilitate care delivery. They have great potential to impact care in low-resource countries,
but have significant ethical concerns pertaining to patient autonomy, safety, and justice.
Objective: To achieve consensus among stakeholders on how to address concerns pertaining
to autonomy, safety, and justice among mHealth developers and users in low-resource
settings, in particular for the application of image-based consultation for diagnostic support.
Methods: A consensus approach was taken during a three-day workshop using a purposive
sample of global mHealth stakeholders (n = 27) professionally and geographically spread.
Throughout a series of introductory talks, group brainstorming, plenary reviews, and synth-
esis by the moderators, lists of actions were generated that address the concerns engendered
by mHealth applications on autonomy, justice and safety, taking into account the develop-
ment, implementation, and scale-up phases of an mHealth application lifecycle.
Results: Several types of actions were recommended; key ones among them included
building in risk mitigation measures from the development stage, establishing inclusive
consultation processes, using open sources platform whenever possible, training all clinical
users, and bearing in mind that the gold standard of care is face-to-face consultation with the
patient. Recommendations of patient, community and health system participation and of
governance were identified as cutting across the mHealth lifecycle.
Conclusion: Priorities agreed-upon at the meeting echo those put forward concerning other
domains and locations of application of mHealth. Those more forcefully articulated are the
need to adopt and maintain participatory processes as well as promoting self-governance.
They are expected to cut across the mHealth lifecycle and are prerequisites to the safeguard
of autonomy, safety and justice.
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Background
The conjunction of smartphones’ increasing versatility
and wireless networks’ widening coverage has sparked
wide-ranging digital approaches in health care [1–3].
Mobile health (mHealth) applications receive support
fromhealth care professionals, for assisting theworkflow,
from institutions concerned with reducing global pov-
erty, for prospects of equitable access to care, and from
promotors of patient empowerment, for facilitating the
process [2,4–6]. Low-resource countries, especially in
Africa, are frequent environments for clinician-to-
clinician applications dedicated to diagnostic and man-
agement assistance, several of which are non-medical like
WhatsApp ®. Despite noteworthy individual and societal
potential benefits addressing the human right for health
care [7], those applications foster tangible ethical con-
cerns pertaining to other human rights like patient auton-
omy, safety, and justice [8–15].At the forefront lie the loss
of privacy inherent in how information is handled, and
threats to patient safety emerging fromweaknesses in the
quality of the digital information inherent in the iterative
development process of mHealth apps [1,6,14,16]. Errors
aswell asmischievous additions are amain concern, from
silent ones, built-in during the app development [17,18],
to those due to the clinical users’ limited qualifications
[18,19], or the unstandardized and unsupervised envir-
onments of use [6,16,19].
Image-based consultation can assist in decision mak-
ing relative to triage, treatment, and disposition, and in
following up treatment progression [20]. Sharing and
receiving images through social media is part of the
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clinical culture of communicating [21] and, often,
a number-one choice [22] for both primary and second-
ary purposes (i.e. patient care versus e.g. medical research
and education). Instant messaging has spread as
a practice and support physician-to-physician systems
in many parts of the world across all resource levels
[23,24], but it presents particular ethical concerns [14].
As for multimedia information, clinical images are trans-
mitted or publishedwithout having either the clinician or
the patient fully aware of the breach in individual privacy
that may occur [20,25]. Also, using clinical images in
tandemwith social media is not the same as telemedicine
[20], which is a real-time event constructed and config-
ured in a way that there are built-in safeguards for pro-
tecting the distribution and storage of the clinical records
that social media does not provide. Further, medical
images are no longer solely taken by professional clinical
photographers [14,20] but, rather, by healthcare provi-
ders thatmay lack specific qualification and training [20].
Currently, recommendations to mitigate concerns
pertaining to the ethical principles of autonomy, safety
and justice are available in the scientific literature and
professional guidelines (e.g. medicine, nursing or engi-
neering) [1,26]. Those compilations are seldom disaggre-
gated according to the stages of the lifecycle of mHealth
applications (development, evaluation of efficacy and
effectiveness, implementation, and scale up) [27], their
acceptance across a range of stakeholders is uncertain,
and their applicability to low-resource settings has
received limited attention. This study aims to fill those
knowledge gaps by investigating what stakeholders from
different settings and backgrounds agree upon and prior-
itize to tackle autonomy, safety, and justice concerns
when using image-based mHealth applications in
resource-poor settings.
Methods
In January 2019, a three-day workshop was held at the
Brocher Foundation [28] co-organized by Swedish and
South African researchers, all involved in point-of-care
mHealth studies in low-resource settings. The follow-
ing ideas guided the preparation for the event:
● Assess the current state of knowledge on poten-
tial ethical concerns.
● Look at solutions one ethical principle at a time
and in consideration of key phases of mHealth
application lifecycle.
● Stimulate individual reflections both before
(providing background documents and check-
lists [1,26] and during the meeting (integrating
brief state-of-the-art presentations).
● Stimulate open discussions where all can have
a say (e.g. through interactive small group ses-
sions and wrap-up plenaries).
The participants consisted of a purposive sample of 27
people, 12 women and 15 men, identified through prior
involvement in similar events, expert reputation, or on
the basis is of their publishedwork in the field. Lay public
and patientswere not invited, due to space considerations
(given the capacity of the venue, there is amaximumof 30
for a Brocher event). We invited 35 participants, but not
all were able to attend. Participants represented their own
views rather than those of their organisation. All were
invited by email, using a standardized letter. They were
employed in governmental agencies, public and private
organisations or universities, and were geographically
and professionally spread, as shown in Table 1.
To determine the most consensual and highly priori-
tised actions that can be taken to safeguard patients’ and
other users’ autonomy, safety, and justice, and to organise
them around critical phases of applications’ lifecycle [27],
we proceeded as follows: from the start, participants were
divided into groups with a geographic, gender and speci-
ality mix, and each group had an assigned chair.
Thematic sessions unfolded, starting with reflections
around patient issues, followed by those around clinical
users and health systems.As indicated in Figure 1, for any
given ethical principle, participants were asked to have in
mind the whole lifecycle of mHealth apps, but they were
not forced to organise their discussions around it.
Likewise, they were asked to consider above all, the
perspective of low-resource settings.
As indicated in Figure 1, throughout a series of intro-
ductory talks, group brainstorming, plenary reviews, and
synthesis by themoderators, a list of solutions susceptible
to help tackle the ethical threats engendered by mHealth
applications at the development phase, implementation
or scale-up eventually materialised. Group discussions
were captured by note taking at each table and by two
rapporteurs. At the end of each session, and at the end of
days 1 and 2, leaders of the initiative met and content-
analysed this material and highlighted priorities that
were agreed upon by the participants.
The participants took part in the workshop on
a voluntary basis and participation did not require
the signature of an informed consent. Approval from
an ethics board was not required.
Table 1. Distribution of the workshop participants by sector
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Results
Autonomy
The 13 actions related to the principle of autonomy and
respect of person concerned, above all, ensuring that
patient data is safely dealt with. This should be addressed
from building-in mechanisms in the development pro-
cess to establishing clear rules at time of scale-up (see
Table 2). Using open source platforms was put forward,
and sowas the user-friendliness of the applications devel-
oped, and even the engagement of all stakeholders
throughout the whole lifecycle. At the implementation
and scale-up phases, informed consent (with all building
components), and understanding and ownership (e.g.
through self-governance) stand out as necessary aspects,
alongside follow up and maintenance of the whole
system.
Safety
Table 3 presents the 14 solutions to mitigate safety
concerns. What stands out is the consensus around
the need to build in safety promoting mechanisms
from the start (and ensuring they are maintained from
then on), and the need for evidence-based processes
and for clear and well-understood rules, procedures
and standards of care. Additional points that come
across from the implementation phase are the impera-
tive need for informed consent, the alignment of safety
promoting rules to already-existing ethical guidelines,
and the empowerment of clinical users in their capacity
to use the system. For implementation and scale-up,
understanding and ownership (e.g. through self-
governance) received priority, alongside follow up and
maintenance. The necessary engagement of all stake-
holders and local governance throughout the whole
lifecycle were both forcefully stressed.
Justice
Table 4 presents the 13 solutions targeting justice, of
which several rests on the application development
phase. Justice was considered in a broad sense, and
included the equal right of access to mHealth, and
Figure 1. Overview of the process followed during the workshop to guide the discussions and generate agreed-upon views on
how to tackle issues pertaining to each ethical principle covered (autonomy, safety, and justice).
Table 2. Synthesis of the priorities raised by the workshop participants related to respect of person and patient autonomy, split into
the main lifecycle phases of mHealth applications.
Development Implementation Scale up/Follow up
Incorporate data security and patient privacy
into the design process
Prioritise and always strive for consent
that is informed, face-to-face, and
individual
Establish clear rules of usage for informal mHealth systems
that are consistent with the existing ethical and
regulatory framework
Have a regulatory framework in place that
safeguards data protection
Make use of existing local ethical
guidelines
Ensure that continuous maintenance and updates of the
system are in place
Use an open source data collection platform Raise mHealth awareness among all
stakeholders
Safeguard and maintain open source platforms
Build in secured mechanisms to facilitate
efficient exchange of data into the existing
health record system
Avoid perverse incentives that interfere
with providers’ decision to use the
system
Foster local governance of digital
applications within the country’s
health care system
Engage all stakeholders throughout the whole process
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also that of being involved in decisions pertaining to
what health issues should receive priority in develop-
ing mHealth solutions.
Discussion
The priorities agreed upon disentangle interventions
needed at specific lifecycle phases, some of which
pertain to more than one phase or touch upon
more than one ethical principle.
Similar requirements albeit a new context
In spite of image-based being the specific field of
application of mHealth covered at the meeting,
many priorities put forward resemble those high-
lighted for mHealth applications in broader fields of
utilization or in better well-off settings [1,3,8–15].
Sovereignty, participation and non-discrimination
cut across all phases, reflecting fairness, respect,
equality, dignity and autonomy as a human rights-
based approach to health care [29].
Having the prevention mechanisms built in from
the start is one example, and it faces a similar barrier:
mHealth app creators are not covered by guidelines
like the Health Information Portability and Privacy
Act (HIPAA) or the International Medical
Informatics Association (IMIA) code, and lack incen-
tive to provide robust information security mechan-
isms. Also echoing other fields of utilization of
mHealth are the need to allow for monitoring and
follow up, and thereby ensure the responsiveness of
a system to both users’ needs and changing environ-
ments. This would, in turn, ensure privacy is main-
tained, patients’ rights are preserved, and diversity of
stakeholders that need to be involved – from within
and outside the health sector – is promoted. One final
similarity is that the instrumentality of mHealth is
emphasized: the gold standard of care must remain
a face-to-face consultation with the patient. Point-of-
care workers must be provided with clear informa-
tion – and trained accordingly – as regards what the
acceptable standard of care in the local health system
context is. Using mHealth solutions should not be an
excuse for substandard care, especially since it is
likely to target patients in resource-poor settings, i.e.
those who are in many respects already worse off.
This is both a safety and a justice issue. Both prior-
itarian and egalitarian considerations of justice imply
Table 3. Synthesis of the priorities raised by the workshop participants related to patient safety, split into the main lifecycle
phases of mHealth applications.
Development Implementation Scale up/Follow up
Proceed to development using a robust scientific
process
Proceed to implementation
following the principles of
implementation science
Ensure ongoing, effective phone stewardship
Incorporate data security and patient privacy into the
design process
Ensure mHealth literacy: all
clinical users are trained in
adequate device stewardship
Assure compliance of the system with a locally-agreed
safety level
Incorporate a robust user authentication system into
the design
Familiarise all clinical users with
the overall process
With systems that employ artificial intelligence, ensure
processes are in place to encourage the maintenance
of clinical staff diagnostic skills
Make explicit the permissible (‘good enough’)
standard-of-care being targeted, and ensure it has
been set in a fair and transparent manner
Define clearly standards of clinical
care that are desirable,
permissible, and forbidden
Ensure continuous quality improvement mechanisms
are in place
Avoid conflicts of interest or perverse incentives for
developers
Engage all stakeholders throughout the whole process
Table 4. Synthesis of the priorities raised by the workshop participants related to justice, split into the main lifecycle phases of
mHealth applications.
Development Implementation Scale up/Follow up
Assure the end product is accessible (i.e. affordable and robust) Include a robust maintenance plan in
the implementation strategy
Identify and prioritise target groups in
a fair and transparent manner
Implement an open source data collection platform Safeguard the engagement of all
stakeholders throughout the
implementation process
Ensure the system is equally accessible to
the entire target group(s)
Incorporate interoperability of the final product into the
existing health care system from inception
Assess the system’s ability to reach out to
all segments of the population/
population groups
Make explicit the permissible (‘good enough’) standard of care
being targeted and ensure it has been set in a fair and
transparent manner
Engage all stakeholders throughout the whole process
Develop apps in a transparent manner
Encourage ‘bottom up’, locally-relevant development that
aligns with local health priorities
Balance use of existing resources with the need to drive
innovation
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that such groups have stronger entitlements to
receive support rather than weaker [30].
Informed consent and governance at the
forefront
The stakeholders emphasized that patient authorization
must remain a prerequisite to any mHealth interven-
tion, something that is particularly critical in image-
based consultation [14,20,31–33]. Data – more or bet-
ter – must not take precedence over patient [9], and
uncertainties experienced by point-of-care workers
[15,18,34,35], in relation with patients and other system
users, must be dealt with. Instrumental to this are the
rights for the users to be consulted at all phases and to
be adequately trained. Beyond individual users, the
stakeholders also insisted on the necessary involvement
of local communities at all phases and on the right to
governance, two points that were not as much empha-
sized in earlier studies. At the workshop, the ‘local’ or
even ‘regional’ character of medical innovations was
stressed in many ways, from requirements to meet
local priorities and engage local stakeholders to others
of using locally-derived or agreed upon clinical stan-
dards and ethical principles.
Informed consent and justice – challenges ahead
The actual feasibility – and ultimately even desirabil-
ity – of informed consent was debated during the
meeting. The discussions were not straightforward –
including the level(s) at which it must be sought
(individual vs community), and who between the
community and the individual patient has the final
word. The notion of informed consent came across as
a complex one; tensions may arise between whose
consent is required (for both primary and secondary
use of information), conflict between community and
individual consent, and the degree to which patients
can be expected to actively engage.
As for justice, there are aspects that need consid-
eration at both group and individual levels. In the
former case, the fact that many mHealth solutions are
meant to reach out to and improve the situation of
(groups of) patients in resource-poor settings, egali-
tarian justice is promoted. But group-level tensions
persist if, for instance, only some health conditions
are targeted by mHealth whereas others are ignored.
How such tensions can be dealt with remains to be
determined. At the meeting, the discussions were
concentrated around distributive principles of justice,
like prioritarian (emphasising the need to reduce the
burden of those worse-off) and egalitarian (reducing
relative inequalities between groups and individuals)
ones, but not as much with other considerations like
that of reciprocity or even responsibility [36]. As
a consequence, whether and in what way aspects of
the like should be built into future guidelines or
revisions of existent ones is uncertain. However,
there was broad consensus in favour of the egalitarian
standpoint favouring equal accessibility to the whole
target group(s). Failure to achieve this gives rise to
legitimate justice-based complaints from the disad-
vantaged individuals within these groups.
Strengths and limitations
The solution-oriented approach that was followed
materialised in prioritized actions that were agreed
upon among knowledgeable and experienced stake-
holders. In events of the like (see other examples in
[35,37], high-level governmental and business people
are typically under-represented [35] and their views are
unweighted [29]. But there are good prospects of colla-
borations aroundmHealth education, delivery and inte-
gration [37] not least in sub-Saharan Africa [38].
The final wording of the suggestions was deter-
mined by the organisers, after participant checks. The
principle- and phase-specific lists were made longer
than shorter: when two or more solutions were inter-
related but not fully overlapping, they were all kept.
This is very apparent for the principle of justice, in
the development phase.
Although the workshop aimed to address ethical
challenges affecting all mHealth users (patients, front-
line and experts) some may have been overshadowed
during the meetings. In addition, due to space con-
siderations, we focussed on groups other than patients
and public: as can be seen from the results, the need
for patients’ voices was strongly emphasised in all
three ethical areas, meaning that this group must be
well represented, not least at any such future events.
Conclusions
The set of propositions resulting from the Brocher
meeting shows that many actions can be taken to safe-
guard that crucial ethical principles as autonomy, safety
and justice be respected when using image-based
mHealth. There is overwhelming consensus regarding
the need to foresee and build-in ethically-oriented solu-
tions from the development stage, and to follow an
evidence-based and inclusive process throughout the
lifecycle of any application. Many see it as essential
that self-governance is a mantra during the whole life-
cycle of mHealth, on all levels and in all its dimensions –
individual, community, heath system, and nation.
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resource settings. Stakeholders gathered at a three-day work-
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relative to front-line users and organizational and technical
environments. Ethical challenges and their potential solutions
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